Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5697242 | Brachytherapy | 2016 | 6 Pages |
Abstract
Brachytherapy should be considered an essential component of definitive chemoradiotherapy for the treatment of neuroendocrine cervical cancer. Chemotherapy timing, however, does not impact outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Tyler P. Robin, Arya Amini, Tracey E. Schefter, Kian Behbakht, Christine M. Fisher,